Equal effects of clopidogrel as compared to aspirin on circulating markers of inflammation in patients with coronary heart disease

被引：0
|
作者：
Solheim, S. [1 ]
Pettersen, A. [1 ]
Arnesen, H. [1 ]
Seljeflot, I. [1 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Clin Cardiovasc Res Unit, N-0407 Oslo, Norway
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81154-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [1] No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
    Solheim, Svein
    Pettersen, Alf Aage
    Arnesen, Harald
    Seljeflot, Ingebjorg
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (05) : 660 - 664
  • [2] Aspirin plus clopidogrel for angina pectoris in coronary heart disease patients
    Zhang, Xin
    Chen, Ju
    Ding, Minzhi
    Zhang, Ning
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13528 - 13534
  • [3] Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
    Lordkipanidze, Marie
    Diodati, Jean G.
    Schampaert, Erick
    Palisaitis, Donald A.
    Pharand, Chantal
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (09): : 1189 - 1193
  • [4] The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease
    Cooke, Glen E.
    Goldschmidt-Clermont, Pascal J.
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (06) : 815 - 826
  • [5] Inflammation markers and coronary heart disease
    Tracy, RP
    CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (05) : 435 - 441
  • [6] Circulating leukocyte-platelet aggregates and biochemical markers of inflammation in patients with coronary heart disease and depression
    Dovlatova, N. L.
    Bouriachkovskaia, L. I.
    Poliakova, E. O.
    Zorin, A. V.
    Uchitel, I. A.
    Sumarokov, A. B.
    Masenko, V. P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 756 - 756
  • [7] Clopidogrel benefits over aspirin in patients with coronary disease
    Harker, LA
    ATHEROSCLEROSIS, 1998, 136 : S31 - S31
  • [8] Effects of periodontal therapy on markers of systemic inflammation in patients with coronary heart disease risk
    Lopez, Nestor J.
    Quintero, Antonio
    Llancaqueo, Marcelo
    Jara, Lilian
    REVISTA MEDICA DE CHILE, 2009, 137 (10) : 1315 - 1322
  • [9] PLASMA CHEMERIN IS ASSOCIATED WITH MARKERS OF INFLAMMATION AND CORONARY ARTERY DISEASE IN PATIENTS NOT ON ASPIRIN
    Herova, M.
    Schmid, M.
    Hersberger, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 87 - 87
  • [10] A randomized controlled trial of aspirin compared to clopidogrel in patients with heart failure
    Parsons, S.
    Rigby, A. S.
    Gittus, C.
    Mcdonagh, T.
    Mcmurray, J. J.
    Squire, I. B.
    Kearney, M. T.
    Taylor, J.
    Wilkinson, I. B.
    Cleland, J. G.
    EUROPEAN HEART JOURNAL, 2014, 35 : 159 - 159
12345